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Abstract
Background. The number of people with Chronic Obstructive Pulmonary Disease (COPD) in Indonesia is 
estimated to continue grow and currently has reached 4.8 million sufferers resulting in a large socio-economic 
burden. Management of COPD requires a comprehensive approach involving rehabilitation activities such as 
Pursed Lip Breathing (PLB) in order to increase the functional capacity of sufferers. Assessment of physical 
functional capacity of COPD patients can be evaluated through the Six Minute Walk Test / 6-minutes walk 
test, which can also assess changes in post-intervention functional capacity such as pulmonary rehabilitation 
programs.
Aims. This study aimed to determine the effect of pulmonary rehabilitation with PLB technique for 4 weeks 
on the achievement of distance through a six-minute road test in COPD patients who received standard 
therapy.
Methods. An experimental, Randomized Controlled Trial (RCT) study was conducted on stable COPD 
patients with classification of Global Initiative for Chronic Obstructive Lung Disease stage II (GOLD 2) 
and GOLD 3 ( Stage III). The study was conducted at the Rumah Sakit Khusus Paru (RSKP) Respira Bantul, 
Yogyakarta. Subjects were taken randomly as a treatment Pursed Lips Breathing (PLB) or control group. 
The treatment group consisted of 38 subjects, doing PLB 8 minutes for 28 days (4 weeks) in a row. The 
placebo group consisted of 37 subjects only continuing the previous standard therapy. Six-minute walking 
test measurements were carried out in both groups before and after treatment and compared between the 
PLB and control groups. The difference in average delta range between groups that received PLB and controls 
was tested by unpaired t-test.
Results. There was a difference increase in the average delta range of the six-minute walk test which was 
not significant between the two study groups. The increase delta mean range in the six-minute walk test 
treatment group was greater (22.19 ± 45.54 meters) compared to the control group (18.54 ± 42.57 m), 
with a P = 0.720.
Conclusion. There was an improvement in functional capacity in the form of increased performance distance 
in the six-minute walk test for COPD patients who received standard therapy and pulmonary rehabilitation 
by pursed-lip breathing (PLB) technique.




Chronic obstructive pulmonary disease 
(COPD) is a chronic progressive pulmonary 
parenchymal disease that is still a global health 
problem. Based on data from the World Health 
Organization (WHO) the number of people 
with COPD in 2005 reached 80 million 
people. It is estimated that in 2020 COPD 
is the 5th out of 12 diseases with the most 
frequent occurrences in the world, and is the 
3rd highest cause of death in the world.
Incidence of COPD in the United States 
in outpatients in hospitals ranges from 76.3%, 
and is the highest cause of death which is 
53.8% compared to other lung diseases. In 
China in 2006, it was estimated that COPD 
sufferers reached 38.1 million. Southeast Asian 
countries such as Vietnam have a COPD 
incidence of 2 million, and in Indonesia there 
are an estimated 4.8 million. This incidence 
will increase with the increasing number of 
smokers, because 90% of COPD sufferers 
are smokers or former smokers. Smokers in 
Indonesia alone in 2004 estimated an estimated 
34.5% and 28.4% smoked every day.
According to the results of Riskesdas in 
2010, that the prevalence of smokers in the 
Special Region of Yogyakarta (DIY) was 31.6% 
and as much as 66.1% still smoked in the house, 
and the percentage of smoke-free households in 
DIY only reached 44.6%. Data from Yogyakarta 
Respira Hospital reported a significant increase 
in the number of outpatient COPD patients in 
2015, which totaled 1598 patients and increased 
to 2495 patients until October 2016.
COPD is a pulmonary disease with the 
characteristics of limited breathing flow that 
is persistent, progressive and is associated 
with an increase in the chronic inflammatory 
Abstrak
Latar Belakang. Jumlah penderita PPOK di Indonesia diperkirakan terus bertambah dan saat ini telah mencapai 
4,8 juta penderita yang mengakibatkan dampak beban sosio-ekonomi yang besar. Penilaian kapasitas fungsional 
fisik penderita PPOK dapat dievaluasi melalui Uji jalan Enam Menit/6-minutes walk test, yang dapat pula 
menilai perubahan kapasitas fungsional pasca intervensi seperti program rehabilitasi paru.
Tujuan. Penelitian ini bertujuan untuk mengetahui pengaruh rehabilitasi paru dengan teknik PLB selama 4 
minggu terhadap capaian jarak tempuh melalui uji jalan enam menit pada penderita PPOK yang mendapatkan 
terapi standar.
Metode. Penelitian eksperimental, Randomized Controlled Trial (RCT), yang dilakukan pada pasien PPOK stabil 
GOLD 2 dan GOLD 3. Penelitian dilakukan di Rumah Sakit Khusus Paru (RSKP) Respira Bantul, Yogyakarta. 
Subjek diambil secara acak sebagai kelompok perlakuan (PLB) atau kontrol. Kelompok perlakuan terdiri dari 38 
subyek, melakukan PLB 8 menit selama 28 hari (4 minggu) berturut-turut. Kelompok plasebo terdiri dari 37 
subyek hanya meneruskan terapi standar sebelumnya. Pengukuran uji jalan enam menit dilakukan pada kedua 
kelompok sebelum dan sesudah perlakuan dan dibandingkan antara kelompok PLB dan kontrol. Beda rerata delta 
capaian jarak antara kelompok yang mendapat PLB dan kontrol  diuji dengan uji-t tidak berpasangan.  
Hasil. Terdapat perbedaan peningkatan delta rerata uji jalan enam menit yang tidak bermakna diantara kedua 
kelompok penelitian. Peningkatan delta mean capaian jarak pada uji jalan enam menit kelompok perlakuan lebih 
besar (22,19 ± 45,54 meter) dibandingkan dengan kelompok kontrol (18,54 ± 42,57 m), dengan nilai P=0,720.
Kesimpulan. Terdapat perbaikan kapasitas fungsional berupa peningkatan jarak capaian pada Uji jalan enam 
menit penderita PPOK yang mendapatkan terapi standar dan rehabilitasi paru dengan teknik pursed-lips breathing 
(PLB) 
Kata Kunci. Penyakit Paru Obstruktif Kronik, Pursed-Lips Breathing, Uji Jalan enam menit.
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2016 - February 2017 and December 2017 
- February 2018. The target population of 
this study was stable COPD patients. The 
affordable population of the study was COPD 
patients who were controls in the pulmonary 
outpatient clinic RSKP Respira. 
Inclusion criteria were stable COPD 
patients with age of GOLD II or III, had 
received routine therapy for at least 3 months 
and were willing to take part in the research as 
evidenced by filling out and signing informed 
consent. Exclusion criteria were COPD 
patients aged > 70 years, liver, kidney, pleural 
effusion, pulmonary tuberculosis, post-
tuberculosis obstruction syndrome, lung 
malignancy, bronchial asthma, angina pectoris 
Canadian Cardiovascular Society (CCS) III, 
angina pectoris unstable, history myocardial 
infarction in the past 1 month, stroke with 
sequel, arthritis in acute conditions, joint injury 
of pelvis, genu and ankle. The drop out criteria 
in this study were subjects experiencing acute 
exacerbations (increased tightness, increased 
sputum production, sputum discoloration) 
during the study period or require an increase 
in drug dosage, do not meet the minimum 
compliance requirements to run a PLB and do 
not experience a 10-15% reduction in pulse 
after doing PLB. Subjects said to be compliant 
if within 4 weeks or 28 days, PLB is run at least 
80% or 22 days. 
The independent variable in this study 
was PLB and the dependent variable was the 
six-minute walk test. Researchers determine 
the groups that received treatment (PLB) and 
control. PLB groups given PLB exercises until 
the subjects done it correctly. Subjects were 
required to do PLB for 8 minutes every day for 
4 weeks. Research data in the form of numerical 
data were presented in mean numbers and 
standard intersections. Statistical analyzes 
response of the airway and lungs. Chronic 
inflammation due to certain particles and gases 
found in cigarettes, further resulting in changes 
in the structure and narrowing of the airway 
in patients with COPD.
Patients with COPD will experience 
increased resistance to air flow, air trapping 
and pulmonary hyperinflation which results 
in decreased lung ventilation function. This 
situation requires an intervention in the form 
of medical rehabilitation to improve ventilation 
function.
Rehabilitation of people with COPD can 
increase physical functional capacity and improve 
quality of life. Rehabilitation of people with 
COPD consists of three components in the form 
of physical, psychosocial and breathing exercises. 
Good physical exercise and breathing can reduce 
and control shortness of breath. One breathing 
exercise technique is pursed-lip breathing (PLB), 
where the PLB training technique activates 
the abdominal muscles during expiration, and 
increases gas exchange and oxygen saturation 
in the arteries. Purse-lip breathing is expected 
to improve breathing patterns, increase tidal 
volume and reduce shortness of breath, thereby 
increasing the functional capacity of people 
with COPD. This study aims to determine the 
effect of pulmonary rehabilitation with PLB 
techniques for four weeks on the results of the 
six minute walk test in patients with COPD who 
get standard therapy.
Methods 
This study used an experimental research 
design, Randomized Controlled Trial (RCT), 
an open label conducted at Respira Special 
Hospital (RSKP) Yogyakarta, Jl. Panembahan 
Senopati No.4 Yogyakarta between October 
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performed by the unpaired T-test were used 
to assess differences in clinical characteristics 
between the PLB and control groups.
Results
The actual sample of the study were 75 
people, consisting of 38 treatment groups and 
37 control groups. The basic characteristics of 
the study subjects were the effect of pursed-lip 
breathing (PLB) on a six-minute walking test 
for 4 weeks in COPD patients including age, 
sex, weight (BB), height (TB), body mass index 
(BMI), routine therapy being undertaken 
and the results of spirometry examinations 
which include FEV1/FVC for the diagnosis 
of COPD, FEV1, FVC and predictive FEV1 
status to determine the severity of COPD 
severity.
The diagnosis and severity can be made 
by measuring FVC and FEV1 with spirometry. 
This measurement serves to measure the speed 
of lung function in breathing air. The FEV1 / 
FVC ratio can be used to determine the degree 
of airway obstruction. COPD sufferers have a 
FEV 1 / FVC ratio <0.7 (GOLD, 2015). The 
severity of COPD is then determined based 
on FEV1 and FEV1 predictions as in table 2 
(GOLD, 2015).
Table 2. Classification of Severity of Airflow 
Obstacles in Patients with COPD
GOLD 
Category
Patients with FEV1/FVC < 0.70
Severity level  FEV1 Measurement
GOLD 1 Mild  FEV1 ≥ 80% prediction
GOLD 2 Moderate 50% ≤ FEV1 < 80% prediction
GOLD 3 Severe 30% ≤ FEV1 < 50% prediction
GOLD 4 Very Severe FEV1 < 30% prediction
 Sources: GOLD, 2015
Figure 1. Study procedure
All patient’s data within October 2016 until February 
2017 and December 2017 until February 2018 
(N=191)
The patient that fulfilled the inclusion criteria as 
assessed on Medical record (N=102)






Drop Out: 6 (12.2%)
Loss of Follow up: 5 (10.2%)
Drop Out: 4 (8.2%)
Loss of Follow Up: 8 (16.3%)
Subjects who could participate in the study for 4 weeks
 (n = 75) 38 treatment groups and 37 control groups. 
Statistical analysis was performed
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The treatment group consisted of 30 
men (78.9%) and 8 women (21.1%) while the 
control group consisted of 24 men (64.9%) 
and 13 women (35 , 1%). The mean age of the 
treatment group was 62.73 ± 7.88 years, while 
the control group was 64.78 ± 8.11 years. The 
mean weight of the treatment group was 54.86 
± 10.58 kg and the control group was 53.18 
± 9.69 kg, the average height of the treatment 
group was 1.6 ± 0.07 m and the control group 
was 1.59 ± 0.06 m, and the mean body mass 
index (BMI) of the treatment group 21.24 ± 
3.41 kg / m2 and the control group 21.06 ± 
3.67 kg/m2. 
After obtaining the mean value of each 
variable before and after treatment, to assess 
the significance of the changes between the 
two study groups, an unpaired T-test was 
performed on the variable mean variable 
between the two groups. Researchers measure 
the achievement of the distance that can be 
traveled by subjects by conducting a six minute 
walk test. The value of the six-minute walk 
test variable obtained from the measurement 
results in each study subject both the treatment 
and control groups are presented in the form 
of a mean and standard deviation both before 
treatment and after treatment.
Table 2. The Changes of Test Variable for the 
Six-Minute Walk Before and After Treatment
Group Control Treatment p
∆ mean IMT -0.2 ± 0.6 -0.09 ± 0.54 0.464
∆ mean FEV1 -1.34 ± 8.05 2.78 ± 11.29 0.012
∆ mean six-
minute walk 18.54 ± 42.57 22.19 ± 45.54 0.720
The unpaired T test, p value <0.05 was considered statistically 
significant difference
An assessment of the change in mileage 
achieved using the Six Minute Road Test 
showed that there was a change in the mean 








Men, n (%) 24 (64.9 %) 30 (78.9 %) 0.427
c
Age, Years (mean ± SD) 64.78 ± 8.11 62.73 ± 7.88 0.307b
Weight, 
Kilograms (mean ± SD) 53.18 ± 9.69 54.86 ± 10.58 0.468
a
Height,
Metre (mean ± SD) 1.59 ± 0.06 1.6 ± 0.07 0.357
b
Body Mass Index  (BMI)
Kg/m2, (mean ± SD) 21.06 ± 3.67 21.24 ± 341 0.822
a
Routine Medication, n (%)
0.593cBronchodilator 8 (21.6%) 10 (26.4%)
Bronchodilator and Steroid 29 (78.4%) 28 (73.6%)
Spirometry
FEV1, Litre (mean ± SD) 0.96±0.34 0.97±0.32 0.912
b
FVC, Litre (mean ± SD) 1.64±0.49 1.63±0.47 0.96b
FEV1/FVC (mean ± SD) 60.69 ± 6.99 57.17 ± 9.48 0.130
b
FEV1 prediction (mean ± SD) 52.93 ± 14.6 54.27 ± 13.55 0.83
b
 Smoking Status
Smokers 26 (70.30%) 26 (68.42%)
0.506c
Non-smokers 11 (29.70%) 12 (31.58%)
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mileage that greater in the treatment group 
compared to the control, which was obtained 
∆ (delta) the average mileage in the treatment 
group was 22.19 ± 45.54 meters compared to 
the control group of 18.54 ± 42.57 meters. 
The difference in mileage obtained used this 
six-minute walk test was not statistically 
significant, p = 0.720.
The final evaluation of the distance 
achieved after treatment in the Six Minute 
Walk Test showed a significant difference (P 
= 0.009) between the Control group (224.86 
± 37.60) against the treatment group (255.43 
± 58.04).
Discussion
The Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) in 2015 
showed a higher prevalence of COPD in men 
compared to women. This is consistent with 
the findings obtained in this study, where 
as many as 54 people (72%) of the research 
subjects were male and the remaining 21 
people (28%) were female with an average age 
of the study subjects aged over 60 years.
Smoking is still a major cause of COPD, 
both active smoking and passive smoking. 
According to the results of Riskesdas in 2010, 
that the prevalence of smokers in the Special 
Region of Yogyakarta (DIY) was 31.6% and 
as much as 66.1% still smoked in the house, 
and the percentage of smoke-free households 
in DIY only reached 44.6%. In this study, 26 
control subjects (70.30%) and 26 treatment 
subjects (68.42%) were smokers.
This study shows the results of differences 
in distance between the control group and the 
treatment group who received PLB breathing 
exercises for 4 weeks. It can be seen (Table 2) 
that the change in the mean distance of the 
control group is smaller than the treatment 
group (∆ the average distance of the control 
group is 18.54 ± 42.57 meters and the 
treatment group is 22.19 ± 45.54 meters), but 
the difference is statistically not significant (p = 
0.720). The results of a comparison analysis of 
the average post-PLB distance achievement in 
the control group (224.86 ± 37.60 meters) to 
the treatment group (255.43 ± 58.04 meters) 
in this study showed a significant increase of 
P = 0.009. 
The results of this study are in accordance 
with research conducted by Bhat et al. (2012) 
involving 14 patients with stable COPD with 
moderate to severe degrees, found a significant 
increase in the results of distance on the 
six-minute walk test on study subjects who 
received PLB with a mean of 34.9 ± 26.4 m 
(p = 0.002 ).
Based on the factors that affect the 
examination of the six-minute walk test 
described by Papathanasiou et al. (2013), 
according to the researchers’ observations 
motivational factors become one of the factors 
that influence the achievement of the distance 
generated by research subjects. Researchers 
see a lack of motivation in research subjects to 
undergo a six-minute walking test in earnest, 
because research subjects immediately want 
to complete the routine control process done 
every month. A systematic review study by 
Roberts et al. (2009) on the use of PLB in stable 
COPD, showed the benefits of a four-week 
PLB program as evidenced by the decrease in 
the index of congestion of research subjects 
when undergoing a six-minute Road test, and 
an increase in the quality of life index in the 
PLB program for 12 weeks. Randomized-
Controlled Trial (RCT) Research by Nield et al. 
(2007) also showed that the PLB group had a 
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significant development after 12 weeks of PLB 
intervention on the symptoms of spasms and 
function performance through a six-minute 
walk test and SF-36.
The PLB technique is proven a simple 
method that can be done in conjunction with 
all activities, without any restrictions related to 
medication and instrumentation. The benefits 
of the PLB program appear to be significant 
after being given for 12 weeks when compared 
to the PLB program for 4 weeks, this shows 
that the benefits of PLB therapy are highly 
dependent on the continuous training process. 
Conclusion
There was a significant increase in 
distance in the Six Minute Road Test for 
COPD patients who received standard therapy 
and pulmonary rehabilitation with pursed lips 
breathing technique (PLB) compared to those 
who only received standard therapy before 
and after treatment. However, there was no 
significant difference in the difference in the 
distance of the achievement of the Six Minute 
Walk Test between before and after treatment 
in groups of COPD patients who received 
standard therapy and pulmonary rehabilitation 
with pursed-lips breathing technique (PLB), 
compared to patients who only received 
standard therapy before and after treatment.
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